Axogen, Inc. to Report Second Quarter 2024 Financial Results and Host Conference Call on August 8, 2024
Axogen, Inc. to Report Second Quarter 2024 Financial Results and Host Conference Call on August 8, 2024
ALACHUA and TAMPA, Fla., July 23, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that it will report second quarter 2024 financial results on Thursday, August 8, 2024, before the market opens. Axogen management will host an investment-community conference call and webcast at 8 a.m. ET following the release.
2024年7月23日,美国Axogen公司(纳斯达克:AXGN)在佛罗里达州ALACHUA和TAMPA宣布,将在2024年8月8日(周四)公布2024年第二季度财报。Axogen管理层将在市场开盘前(美国东部时间8:00 a.m.)召开投资者电话会议和网络直播。
Investors interested in participating in the conference call by phone may do so by dialing toll free at (877) 407-0993 or using the direct dial-in number at (201) 689-8795. Those interested in listening to the conference call live via the Internet may do so by visiting the Investors page of the Company's website at and clicking on the webcast link.
希望通过电话参加电话会议的投资者可以拨打免费电话(877)407-0993或直接拨打(201)689-8795。有兴趣通过互联网收听电话会议现场直播的人可以访问公司网站的投资者页面,点击网络直播链接。
Following the conference call, a replay will be available in the Investors section of the Company's website at .
电话会议结束后,回放可以在公司网站的投资者部分找到。
About Axogen
Axogen(AXGN)是专门关注外周神经再生和修复的科学、开发和商业化技术的领先公司。Axogen员工致力于通过为外周神经受损或切断患者提供创新、经过临床验证的有效修复方案,帮助恢复其神经功能和生活质量。每天都有人遭受外周神经的创伤或接受影响其外周神经功能的手术。如果有外周神经受损或者无法正确重新连接周围神经,就会出现失去肌肉或器官功能、失去感觉或疼痛产生等症状。
Axogen (AXGN) is the leading Company focused specifically on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. Axogen employees are passionate about helping to restore peripheral nerve function and quality of life to patients with physical damage or transection to peripheral nerves by providing innovative, clinically proven, and economically effective repair solutions for surgeons and health care providers. Peripheral nerves provide the pathways for both motor and sensory signals throughout the body. Every day, people suffer traumatic injuries or undergo surgical procedures that impact the function of their peripheral nerves. Physical damage to a peripheral nerve, or the inability to properly reconnect peripheral nerves, can result in the loss of muscle or organ function, the loss of sensory feeling, or the initiation of pain.
Axogen的外周神经修复平台包括广泛的产品组合,用于各种应用和外科专业,包括创伤损伤、口腔和颌面外科手术、乳房重建和疼痛的外科治疗。这些应用涵盖计划预约手术和紧急手术。具体而言,计划预约手术通常由寻求缓解因神经缺陷或前期手术干预引起的病症的患者进行。这些手术包括手术治疗乳腺切除术后的女性感觉缺失,手术切除疼痛性神经瘤后的神经重建,口腔和颌面程序以及神经减压。相反,紧急手术通常由在急诊室首次出现的损伤,或者专家了解到初始损伤后立即或在几天内进行干预。这种广泛的应用范围凸显了Axogen在外周神经修复中对应患者需求的关键作用。
Axogen's platform for peripheral nerve repair features a comprehensive portfolio of products used across various applications and surgical specialties, including traumatic injuries, oral and maxillofacial surgery, breast reconstruction, and the surgical treatment of pain. These applications encompass both scheduled and emergent procedures. Specifically, scheduled procedures are often pursued by patients seeking relief from conditions caused by a nerve defect or previous surgical interventions. Such procedures include providing sensation for women undergoing breast reconstruction following a mastectomy, nerve reconstruction after the surgical removal of painful neuromas, and oral and maxillofacial procedures, as well as nerve decompression. Conversely, emergent procedures typically arise from injuries that initially present in an emergency room, with specialists intervening either immediately or within a few days following the initial injury. This broad range of applications underscores Axogen's vital role in addressing diverse patient needs in peripheral nerve repair.
Axogen的外周神经修复平台包括Avance神经移植材料,这是一种活性处理的人类神经移植材料,可用于桥接已切断的外周神经,而不会出现第二个手术部位的并发症;Axoguard神经连接器,这是一种猪黏膜外细胞基质(ECM)协助牵合,从而无张力地修复切断的外周神经;Axoguard神经保护垫,这是一种猪黏膜外细胞基质(ECM)产品,用于包裹和保护受损的外周神经,并在防止软组织附着的同时加固神经重建;Axoguard HA+神经保护垫,这是一种猪黏膜表层涂有专有的透明质酸-海藻酸盐凝胶的细胞外基质,这是一种下一代技术,旨在增强神经滑动,并为外周神经损伤提供短期和长期保护;Avive+医用多层胚胎膜支架,这是一种多层羊膜移植物,可用于在手术床位上保护和分离组织,在组织修复的关键阶段起到重要作用;以及Axoguard神经帽,这是一种猪黏膜外细胞基质(ECM)产品,用于保护外周神经末梢并分离神经与周围环境,以减少症状性或疼痛性神经瘤的发展。Axogen产品组合在美国、加拿大、英国、韩国和欧洲其他几个国家和地区均可购买。
Axogen's platform for peripheral nerve repair features a comprehensive portfolio of products, including Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; Axoguard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; Axoguard Nerve Protector, a porcine submucosa ECM product used to wrap and protect damaged peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments; Axoguard HA+ Nerve Protector, a porcine submucosa ECM base layer coated with a proprietary hyaluronate-alginate gel, a next-generation technology designed to enhance nerve gliding and provide short- and long-term protection for peripheral nerve injuries; Avive+ Soft Tissue Matrix, a multi-layer amniotic membrane allograft used to protect and separate tissues in the surgical bed during the critical phase of tissue repair; and Axoguard Nerve Cap, a porcine submucosa ECM product used to protect a peripheral nerve end and separate the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma. The Axogen portfolio of products is available in the United States, Canada, the United Kingdom, South Korea, and several other European and international markets.
Axogen公司致力于开发和销售创新的外周神经损伤手术解决方案,其包含全面的周围神经修复平台,如将细胞外基质(ECM)用于连接,保护和加固受损的周围神经,同时防止软组织粘连和减小后遗症。Axogen公司的产品包括静脉脉搏神经移植组织Avance、猪皮下组织细胞外基质接合物Axoguard、猪子宫颈部位组织ECm保护神经康复Axoguard、基于山梨酸盐-藻酸盐凝胶薄膜涂覆的猪皮下组织细胞外基质保护神经康复Axoguard HA +、多层羊膜移植组织Avive + Soft Tissue Matrix,以及猪子宫颈部位组织ECm防止术后疼痛神经瘤Axoguard Nerve Cap等,并且这些产品在美国、加拿大、英国、韩国等国家和地区都可以购买。
For more information, visit
要获取更多信息,请访问
Contact:
Axogen, Inc.
Harold D. Tamayo, Vice President of Finance and Investor Relations
htamayo@axogeninc.com
联系方式:
Axogen,Inc。
Harold D. Tamayo,财务副总裁兼投资者关系。
htamayo@axogeninc.com